Emerging view of the human virome  by Wylie, Kristine M. et al.
Emerging view of the human viromeKRISTINE M. WYLIE, GEORGE M. WEINSTOCK, and GREGORY A. STORCH
ST. LOUIS, MOFrom The Genome Insititute; Depa
University School of Medicine, St.
All authors have read the policy on
interest, and the authors have no fin
terest to disclose.
Submitted for publication Decem
March 28, 2012; accepted for publ
Reprint requests: Kristine M. Wylie
Institute, Washington University S
Park Avenue, St. Louis, MO.
1931-5244
 2012 Mosby, Inc.
doi:10.1016/j.trsl.2012.03.006
Open access undThe human virome is the collection of all viruses that are found in or on humans,
including both eukaryotic and prokaryotic viruses. Eukaryotic viruses clearly
have important effects on human health, ranging from mild, self-limited acute or
chronic infections to those with serious or fatal consequences. Prokaryotic viruses
can also influence human health by affecting bacterial community structure and
function. Therefore, definition of the virome is an important step toward understand-
ing how microbes affect human health and disease. We review progress in virome
analysis, which has been driven by advances in high-throughput, deep sequenc-
ing technology. Highlights from these studies include the association of viruses
with clinical phenotypes and description of novel viruses that may be important
pathogens. Together these studies indicate that analysis of the human virome is
critical as we aim to understand how microbial communities influence human
health and disease. Descriptions of the human virome will stimulate future work
to understand how the virome affects long-term human health, immunity, and re-
sponse to coinfections. Analysis of the virome ultimately may affect the treatment
of patients with a variety of clinical syndromes. (Translational Research
2012;160:283–290)Abbreviations: CF ¼ cystic fibrosis; HMP ¼ Human Microbiome Project; RTG ¼ Real Time
GenomicsT he viral component of the human microbiome isreferred to as the ‘‘human virome.’’ The humanvirome (also referred to as the ‘‘viral metage-
nome’’) is the collection of all viruses that are found
in or on humans, including viruses causing acute, persis-
tent, or latent infection, and viruses integrated into the
human genome, such as endogenous retroviruses. Thertment of Pediatrics, Washington
Louis, Mo.
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er CC BY-NC-ND license.human virome includes both eukaryotic and prokaryotic
viruses (bacteriophages). Eukaryotic viruses clearly
have important effects on human health. Viral infections
of humans include acute, self-limited infections; fulmi-
nant, uncontrolled acute infections; and chronic infec-
tions that may be asymptomatic or associated with
serious, even fatal diseases, such as acquired immuno-
deficiency syndrome.1 Furthermore, many diseases of
unknown cause are thought to be of viral origin.2
Human endogenous retroviruses comprise greater than
8% of the human genome.3 They are transcribed ubiqui-
tously in normal tissues.4 There has been preliminary
evidence of their association with diseases, including
amyotrophic lateral sclerosis, multiple sclerosis, and
rheumatoid arthritis;5-7 however, the association has
not been shown to be causal. Bacteriophages may also
affect human health because they can influence bacterial
population structure or virulence.8 Advances in
high-throughput, deep sequencing technology make it
possible to characterize virome richness and stability,
gene functions, and association with disease283
Fig 1. Components of the human virome. Circles represent components of the virome that can be characterized by
metagenomic sequencing. These categories are not mutually exclusive. After viruses are identified, their effects on
human health and the microbial community must be determined. Examples of questions and implications that are
associated with each component of the virome are listed in the boxes.
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the richness of the virome and the role viruses play
within complex microbial communities (Fig 1).
CHALLENGES FOR VIROME STUDIES
The study of the virome is challenging for several rea-
sons. First, viruses do not contain a conserved genomic
region that can be used to identify the viruses in a micro-
bial community, such as the 16S rRNA gene that is used
to classify bacteria. Instead, the entire viral community
must be sampled and viral genomic sequences com-
pared with known viral reference sequences. The suc-
cess of this process is currently limited by the fact that
many viruses have not yet been characterized and are
not included in viral reference databases.10 Further-
more, viral sequences with poor homology to known
viruses may be difficult to classify.
The second challenge in studying the virome is that
viral genomic material can be a small proportion of
the total nucleic acid in microbial communities becauseof the small genome sizes of most viruses and their low-
level presence in some cases. This is particularly true for
eukaryotic viruses producing persistent asymptomatic
infection that may have as yet unappreciated effects
on long-term human health.11 Polymerase chain reac-
tion and culture are tools that can be used to characterize
the virome. However, the use of these approaches
requires up-front decisions about which viruses to
look for, thus providing an informative but more limited
view of the scope of the virome. Viral nucleic acids can
be enriched using hybridization techniques such as
microarray or capture,12-19 and bound nucleic acids
can subsequently be sequenced to provide additional
information about the viral genomes. Some novel
viruses can be detected by these methods if there is suf-
ficient sequence homology to bind the viral probes.20-23
Enrichment of viral particles via filtration and gradient
centrifugation24 can enhance the viral signal. However,
enrichment techniques can bias against certain types of
viruses, and intracellular and low-abundance viruses
Translational Research
Volume 160, Number 4 Wylie et al 285can be lost during the enrichment process.24 High-
throughput, deep sequencing technology is revolution-
ary, because it provides an unbiased approach that can
detect even rare components of a microbial community.
Nucleotide sequencing delivers great power for
detecting known and novel viruses in clinical samples.
Less than 10 years ago, the ABI 3730 capillary
sequencer (Applied Biosystems, Foster City, CA) was
the state-of-the-art platform for high-throughput
sequencing, simultaneously generating sequences
from 96 clones on a single run. The lengths of sequences
generated on this platform are typically 500 to 800
bases. This relatively long length can be advantageous
for discovering novel microbes with remote homologies
to reference sequences. However, ABI 3730 sequencing
requires that the novel microbe be abundant in the orig-
inal sample or cloned, because the cost per read limits
the number of sequences that can be generated in an
experiment. Sequences generated on the ABI 3730
were used for the initial sequence-based characteriza-
tions of nonviral microbial communities and for early
studies in which novel viral pathogens were detected
(discussed below).
In the decade since capillary sequencing was used for
the Human Genome Project, technology has increased
the yield of sequence that can be generated per day
from a single instrument by .30,000-fold while reduc-
ing cost by approximately 7000-fold. With the advent of
massively parallel sequencing platforms, such as the
Roche 454 pyrosequencer (454 Life Sciences, Branford,
CT), sequencing capacity grew to approximately 1 mil-
lion sequences per run, each 250 to 500 bases in length,
resulting in a total sequence throughput of up to 500
million bases per run. By introducing sequence ‘‘barco-
des’’ during sample amplification, multiple samples can
be pooled within a single run, allowing generation of
tens to hundreds of thousands of sequences per sample.
This massively parallel sequencing allows a more thor-
ough assessment of microbial communities that in-
cludes the description of lower abundance microbes.
Indeed, analysis of stool samples on the Roche 454 plat-
form revealed a greater number of viruses compared
with the ABI 3730.25 Many novel viruses were discov-
ered using the Roche platform (discussed below). The
Illumina Genome Analyzer (Illumina Inc, San Diego,
CA) generates up to 640 million sequences per run,
and the Illumina HiSeq 2000 can generate up to 6 billion
paired-end sequences per run. On each of these plat-
forms, multiple pooled, barcoded samples can be in-
cluded on each run. Illumina sequences are shorter
than those generated by Roche 454 pyrosequencing:
In early experiments, they were less than 50 bases in
length but now are routinely 100 bases. Although the
read length is short, sequences can be generated fromboth ends of a DNA fragment to yield ‘‘paired-end’’
reads, allowing 200 bases to be sequenced from the
same DNA fragment. Illumina technology provides
the sensitivity needed to detect rare virus sequences,
with sensitivity comparable to that of quantitative re-
verse transcriptase polymerase chain reaction in some
studies.26 The short lengths seem to be sufficient for de-
tecting novel viruses within a sample of a microbial
community.27 Assembly of Illumina sequences can
also be used to achieve longer contiguous sequences,27
and assembly programs such as PRICE have been devel-
oped to extend a fragment of sequence from a novel or-
ganism iteratively using paired-end Illumina data
(DeRisi, unpublished, available at: http://derisilab.
ucsf.edu/software/price/index.html). Trends toward in-
creasing numbers of sequences per run and decreased
cost per base are likely to continue. New sequencing
platforms, including the Illumina MiSeq and the Life
Technologies (Grand Island, NY) Ion Torrent Personal
Genome Machine Sequencer, are being developed to
generate large amounts of sequence data with a rapid
turnaround time.
Rapid, accurate analysis of sequence data is critical
for research, with more stringent requirements antici-
pated as clinical applications for virome analysis are de-
veloped. Identification of viral sequences is generally
achieved by comparison of microbial sequences with
reference genomes. Use of programs such as BLAST
and BLASTX28 is the traditional method for doing
this; these programs work well for relatively small
data sets generated by the ABI 3730 and Roche 454 py-
rosequencer or for longer contiguous sequences assem-
bled from shorter Illumina reads. However, analyzing
millions to billions of Illumina Genome Analyzer se-
quences requires faster aligners. Many short-read se-
quence alignment tools are fast but have low tolerance
for sequence mismatches; however, virus sequences
may differ significantly from the reference genome se-
quences, so allowing mismatches in the alignments is
critical.
Martin and colleagues29 provide a thorough compari-
son of nucleotide alignment tools for short sequences.
CLC bio (www.clcbio.com) and Real Time Genomics
(RTG) (www.realtimegenomics.com) software were
chosen from the tools evaluated, and they were used ex-
tensively to carry out nucleotide alignments of the tera-
bases of Illumina data generated in the Human
Microbiome Project (HMP); MBLASTX from Multi
Core Ware (www.multicorewareinc.com) and RTG
mapx software were used for HMP translated sequence
alignments (HMP Consortium, manuscript in revision,
2012). These programs provide 100- to 1000-fold in-
creases in alignment speed over BLAST and BLASTX
while maintaining similar sensitivities (MBLASTX,
Translational Research
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Mitreva et al, manuscript in preparation, 2012). Al-
though identification of virus sequences based on se-
quence homology to known viruses is straightforward
in concept, one must be cautious in interpreting the
data. Low-complexity sequence and sequences with ho-
mology between virus and host can cause false-positive
viral identifications. Likewise, false-positive identifica-
tions can occur when a sequence does not have close
homology to a sequence in the reference database;
some general functions are conserved among eukary-
otes, bacteria, and DNA viruses, which can result in
a weak alignment of translated sequence. Further analy-
sis of virome diversity and complexity can be achieved
using software packages, such as GAAS,30 Metavir,31
and PHACCS.32 Expertise in the computational
challenges of virome analysis will be needed as virome
studies become more widespread and move toward
clinical applications.SEQUENCE-BASED VIROME ANALYSIS
Some of the first virome analyses were carried out on
environmental samples, particularly those from ocean
water.33,34 In a study by Breitbart et al,33 viral DNA
was isolated from surface seawater collected in La
Jolla and San Diego, California, and approximately
1000 sequences were generated from each sample.
Chao1 estimates and rank abundance curves predicted
that hundreds to thousands of viral genotypes were
present in the viral communities. Significant align-
ments were identified to all major families of dsDNA
tailed phages. In addition, 65% of the sequences
were unclassified, pointing to the existence of vast ge-
nomic diversity in the oceanic ecosystem, including
many novel viruses. Angly et al34 expanded the virome
analysis to 4 distinct oceanic regions (Sargasso Sea,
Gulf of Mexico, seawater off the coast of British Co-
lumbia, and the Arctic ocean) and analyzed samples
collected at different time points, locations, and depths.
More than 1.7 million sequences were generated using
the Roche 454 platform. These sequences were rela-
tively short, with an average length of 102 bases. Oce-
anic environments contained distinct phage groups that
reflected the composition of the bacterial community in
that niche, as well as some phages that were common to
all or some environments. The diversity and richness of
phage populations were different in the 4 environments
described. These data suggest that phage communities
in different ecologic niches will differ with respect to
the environment in which they are found, in part reflect-
ing the resident bacterial population and its functions.
This work also suggests that the study of the viral pop-
ulations in a variety of human body habitats will revealan unappreciated diversity of common and specialized
viruses.
Early sequence-based analyses of the virome in sam-
ples from humans focused on bacteriophage popula-
tions. Bacteriophages influence their host bacteria and
contribute genes that affect the structure and functions
of microbial communities.35,36 Therefore, bacterio-
phages may be both important effectors and indicators
of human health and disease. In the first characterization
of a bacteriophage community in a human stool sample,
shotgun sequencing of 532 cloned viral DNA fragments
from the stool of a healthy adult revealed that the major-
ity of phage sequences were novel.37 The data suggested
rich diversity of bacteriophage sequences, with approx-
imately 2 to 5 times the number of bacteriophage geno-
types as predicted bacterial genera in a stool community
(1200–2000 genotypes predicted).37 In contrast, a sim-
ple but dynamic bacteriophage community (8 geno-
types predicted) was observed by sequencing 477 viral
DNA clones from feces of a 1-week-old infant.38 These
studies suggest that the diversity of bacteriophages in
the gut expands as the bacterial community is estab-
lished,38 but a larger group of adults and infants will
need to be sampled and compared to validate this con-
clusion. In fact, more recent studies that include sam-
ples from more individuals and use deeper sequencing
indicate that the richness of bacteriophage populations
in stool communities varies greatly among adults. In
one study, Reyes et al39 found 10 to 984 genotypes
per sample from 12 individuals. In another study, Minot
et al40 found 19 to 785 genotypes per sample from
16 individuals. Thus, although important changes in
the virome may occur as the infant gut matures, it is
likely that the changes are more complex than simply
increased diversity.
The insights into the human virome (particularly the
bacteriophage component) provided by studies by
Reyes et al39 and Minot et al40 were made possible in
large part because of newer sequencing technologies,
especially the Roche 454 pyrosequencing platform.
Consistent with the earlier studies, most viral sequences
obtained were novel. Both studies showed relative sta-
bility of the virome over time (days to years), although
changes in diet that affected the bacterial communities
also correlated with changes in the viral communities.40
The depth of sequencing enabled the assembly of longer
contiguous sequences that were used to identify remote
homologies and open reading frames for functional
analysis. Of importance, the studies by Reyes et al
and Minot et al show that bacteriophages encode antibi-
otic resistance genes40 and other genes associated with
bacterial metabolic pathways.39,40 Also, like bacterial
plasmids, bacteriophages serve as reservoirs for mobile
genetic elements in bacteria. In turn, this suggests that
Translational Research
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ing to or changing the metabolic capabilities of the res-
ident bacterial community.
The perturbation of a microbial environment by a dis-
ease, such as cystic fibrosis (CF), can cause changes in
the microbiome. Willner et al41 studied the viral meta-
genome of the respiratory tract by analyzing sputum
samples from 5 patients with CF and 5 controls without
CF.41 The study describes bacteriophage communities
in healthy people that were unique to each individual
and were thought to reflect a random, transient sampling
of the external environment. However, bacteriophage
communities from individuals with CF were similar to
each other, presumably driven by effects of their airway
pathology. The spouse of a CF patient and a control with
asthma, neither of whom had CF, shared the distinct sets
of viral taxa and predicted host range found in the indi-
viduals with CF. These data lead to 2 important infer-
ences. The first is that environment can have a strong
influence on an individual’s microbiome, including the
virome. In this study, the presence of shared organisms
between spouses was striking, indicating a shared ex-
ternal environment. The microbial community was
thought to be transient in the spouse without CF but
more established in the patient with CF, in whom clear-
ance of microbes is impaired. The second inference is
that similar microbial communities may be established
in response to distinct health conditions, such as CF
and asthma, both of which may cause impaired clear-
ance of microbes from the airways. Together, these
data suggest that in addition to the components of the
virome, the dynamics of the viral community may be
important for distinguishing the effects of the virome
in different microenvironments.
The studies discussed thus far evaluated DNAviruses,
but many important RNA viruses that infect eukaryotic
cells also are found in the gastrointestinal and respira-
tory tracts. Eukaryotic viruses are found less frequently
than bacteriophages in many microbial communities,
and indeed the stool and sputum samples evaluated con-
tained only a few sequences with homology to eukary-
otic DNA viruses.39-41 It is likely that more eukaryotic
viruses would be found by inclusion of RNA in the anal-
ysis (particularly in the respiratory tract). A study that
evaluated RNA viruses in stool samples from 2 healthy
individuals found a diverse array of viruses.42 Although
some human viruses (picobirnaviruses) were detected in
this study, most of the RNAviruses detected were plant
viruses, which were most likely found in the stool as
a by-product of diet.
Raw sewage and reclaimed water provide source ma-
terial for virus discovery and the evaluation of emerging
pathogens.43-45 DNA and RNA virus sequences from
raw sewage collected at several sites43 revealed a viralcommunity that was dominated by bacteriophages and
the subset of eukaryotic viruses that were predomi-
nantly from plants. Seventeen known human viruses
were detected. Strikingly, novel viruses belonging to
51 virus families were also detected. These data indicate
that environmental samples that contain specimens
from a large number of individuals can provide valuable
information concerning viruses present in the popula-
tion, including novel agents in addition to known human
pathogens.VIROME AND DISEASE: THE DISCOVERY OF NOVEL
EUKARYOTIC VIRUSES
Overall, eukaryotic viruses are minor components of
a microbial community, although their effects are often
readily observed. Titers of eukaryotic viruses are gener-
ally higher in samples from symptomatic versus asymp-
tomatic individuals. Thus, some of the viral metagenomic
studies of the human gastrointestinal tract evaluated stool
from patients with diarrhea46 and non-polio acute flaccid
paralysis.25 The samples evaluated (from 12 and 35
patients, respectively) contained a variety of DNA and
RNA viruses, including human enteroviruses, adenovi-
ruses, caliciviruses, and parvoviruses. The eukaryotic
viral metagenomes were distinct in each subject. Viral
sequences accounted for the majority of sequences that
were present in some subjects. The use of the Roche
454 pyrosequencing platform, which generated more se-
quences per sample than the ABI 3730 platform, revealed
a greater richness in the eukaryotic viral metagenome.25
This indicates that depth of sampling is an important fac-
tor for comprehensive viral metagenomic analysis and
for discovering novel eukaryotic viruses. In addition to
the detection of known viruses, each of these studies
identified novel viruses associated with diarrhea, includ-
ing an astrovirus,46 a cosavirus, and a bocavirus,25 among
others. Novel viruses identified by these viral metage-
nomic studies must be subject to extensive further study
to determine whether they are causally associated with
human disease.47
The identification of novel viruses is an exciting part
of the characterization of the virome. Most of the viral
sequences detected in deep sequencing experiments
are uncharacterized (described above), indicating the
presence of great viral diversity to be discovered. These
undiscovered viruses may affect human health, either
acutely or through chronic infection.11 Indeed, many
conditions, including fever, diarrhea, and respiratory ill-
ness, may be caused by unknown or undiagnosed path-
ogens that are suspected to be viral. In recent years,
many novel eukaryotic viruses have been discovered
or characterized using sequencing, including viruses in
the following groups: arenaviruses,48 astroviruses,46,49,50
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maviruses,52,53 bocaviruses,54 enteroviruses,55 and
klasseviruses,56 among others. Many more viruses
undoubtedly remain to be discovered, and further char-
acterization of viral strains and subtypes is an important
goal.57
Discoveries about the presence and dynamics of
known viruses in the virome may also affect the way
we view their impact on human health. For instance,
viruses that integrate into the human genome have
been associated with cancer (eg, human papillomavirus
16, Epstein–Barr virus, and the more recently discov-
ered Merkel cell polyomavirus). As we characterize
the human virome, distinguishing episomal from inte-
grated viruses is an important goal that may relate to
the understanding of disease. In addition, virome analy-
sis may identify known viruses in unexpected tissues,
which could suggest novel mechanisms of disease.THE FUTURE: CLINICAL APPLICATIONS OF HUMAN
VIROME STUDIES
The most immediate applications of virome studies
relate to the discovery of new viral pathogens (see
above) or viruses with previously unappreciated
tropisms.58,59 Ongoing viral metagenomic analyses
will undoubtedly reveal the presence of additional novel
viruses. Significant evidence must be accrued to relate
novel viruses to disease phenotypes. As evidence asso-
ciating novel viruses with disease phenotypes accumu-
lates, these new viruses will be considered as potential
causes for disease. For instance, since their discovery
in 2005,54 bocaviruses have been associated with respi-
ratory illness and diarrhea;60 however, their roles as
pathogens have not yet been formally established. De-
tailed studies will be required to establish causal rela-
tionships between viruses and disease.
An intriguing question is whether viral metagenomic
analysis can be applied as a clinical diagnostic method.
The concept is appealing because a sequencing-based
approach could dramatically increase the range of
viruses detected in clinical samples compared with
existing diagnostic methods. In some recent studies,
sequence-based analysis of viral communities has had
sensitivity comparable to virus-specific polymerase
chain reaction.26 Alternative approaches would be to en-
rich for viral nucleic acids by carrying out hybridization
or alternatively to remove human nucleic acid before se-
quencing.12-14 Important methodological questions that
need to be addressed include which samples should be
selected for analysis, what sample preparation method
should be used, and which sequencing platform should
be used. In addition, extensive work remains to be
done by laboratorians and clinicians to understand theclinical significance of the data generated. Finally,
significant practical barriers remain to be surmounted,
including decreasing the time required for sample-to-
result analysis and decreasing cost. Although further
technologic progress in both sequencing and informa-
tion processing will be required to meet these goals,
the pace of recent advances suggests that this may occur
in the relatively near future.CONCLUSIONS
We envision that in some patients who are diagnostic
mysteries, rapid, unbiased sequence analysis of the viral
metagenome in several samples from the patient will be
used to generate a list of medically relevant viruses and
genes that are detected, which can be further evaluated
and confirmed using virus-specific assays. The viral
metagenomic data will then be considered along with
clinical data to determine whether (a) the virus or
viruses can have a causal relationship to the patient’s
illness or (b) genes encoded by the virus may affect
a planned treatment (antibiotic or antiviral resistance).
In the future, as we begin to understand how the virome
affects long-term human health, immunity, and
response to coinfections or treatments, analysis of the
virome may become highly informative for patient
management.REFERENCES
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